How much funding has LifeMine raised?

LifeMine has raised $188.0M in total funding, most recently a Series E round.

Who are LifeMine's investors?

LifeMine's investors include Milky Way Investments Group, Bezos Expeditions, Gates Frontier, RA Capital Management, GV, GSK.

Where is LifeMine headquartered?

LifeMine is headquartered in Watertown, Massachusetts, United States.

LifeMine

Mining the Medicines of Life.

Watertown, United States · Founded 2016 · $188.0M raised

Biotech

Headquarters: Watertown, Massachusetts
Founded: 2016
Business Model: B2B
Website: lifeminetx.com

Total Funding: $188.0M
Last Round: $188.0M Series EAug 2026
Rounds: 1

About

LifeMine Therapeutics is a clinical-stage biopharmaceutical company pioneering Top-Down Drug Discovery, a novel approach that leverages evolutionary insights from fungi to identify next-generation precision medicines. The company has built the world's largest fully genomicized fungal strain collection — comprising over 100,000 deep-sequenced wild-type fungi — and uses genomics, AI, and synthetic biology to discover structurally novel small-molecule therapeutics. LifeMine's lead program, LIFE-001, is a precision-engineered calcineurin inhibitor in Phase 1 clinical trials for immune-mediated disorders and organ transplant rejection, with global operations in Watertown MA, Gloucester MA, and Basel, Switzerland.

Summary

LifeMine is a Biotech company based in Watertown, United States, founded in 2016. It has raised $188.0M in total across 1 round, most recently a $188.0M Series E round in Aug 2026. Investors include Milky Way Investments Group, Bezos Expeditions and Gates Frontier.